Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 09, 2023

BUY
$11.12 - $22.2 $41,277 - $82,406
3,712 Added 8.51%
47,333 $542,000
Q1 2023

May 09, 2023

SELL
$18.7 - $23.07 $8,770 - $10,819
-469 Reduced 1.06%
43,621 $878,000
Q4 2022

Feb 13, 2023

BUY
$18.12 - $27.32 $120,008 - $180,940
6,623 Added 17.68%
44,090 $1 Million
Q3 2022

Nov 14, 2022

BUY
$16.98 - $25.54 $72,980 - $109,770
4,298 Added 12.96%
37,467 $703,000
Q2 2022

Aug 15, 2022

BUY
$13.15 - $20.45 $27,522 - $42,801
2,093 Added 6.74%
33,169 $618,000
Q1 2022

May 12, 2022

BUY
$14.54 - $21.5 $55,819 - $82,538
3,839 Added 14.09%
31,076 $562,000
Q4 2021

Feb 11, 2022

SELL
$20.24 - $36.01 $222 - $396
-11 Reduced 0.04%
27,237 $565,000
Q3 2021

Nov 10, 2021

BUY
$26.01 - $38.22 $708,720 - $1.04 Million
27,248 New
27,248 $872,000
Q4 2019

Feb 11, 2020

SELL
$37.13 - $74.62 $319,318 - $641,732
-8,600 Closed
0 $0
Q3 2019

Nov 14, 2019

SELL
$39.36 - $76.8 $901,344 - $1.76 Million
-22,900 Reduced 72.7%
8,600 $338,000
Q2 2019

Aug 13, 2019

BUY
$52.76 - $82.19 $1.66 Million - $2.59 Million
31,500 New
31,500 $2.46 Million

Others Institutions Holding QURE

About uniQure N.V.


  • Ticker QURE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,729,100
  • Market Cap $300M
  • Description
  • uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...
More about QURE
Track This Portfolio

Track Commonwealth Of Pennsylvania Public School Empls Retrmt Sys Portfolio

Follow Commonwealth Of Pennsylvania Public School Empls Retrmt Sys and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Commonwealth Of Pennsylvania Public School Empls Retrmt Sys, based on Form 13F filings with the SEC.

News

Stay updated on Commonwealth Of Pennsylvania Public School Empls Retrmt Sys with notifications on news.